Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma.
Michael Jw ThompsonVenkat ParameswaranJohn R BurgessPublished in: Annals of clinical biochemistry (2018)
Chromogranin A does not provide additive benefit to standard surveillance for predicting the presence of SDHB- or SDHD-related paraganglioma, but has a useful negative predictive value when normal in patients with SDHB mutation.
Keyphrases